Research and Markets: Global Human Vaccines Market 2011-2015

Research and Markets has announced the addition of the "Global Human Vaccines Market 2011-2015" report to their offering.
Executive Summary
TechNavio Announces the Publication of its Report - Global Human Vaccines Market 2011-2015
Buy Aldara (Imiquimod) pills online without prescription TechNavio today launched its report Global Human Vaccines Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers and understanding of the present and the future landscape of the market.
Commenting on the report, an analyst from TechNavio's Healthcare team said; 'The Global Human Vaccines market possesses enough growth opportunities for the vendors in the market because of the high demand for different vaccines that can counter diseases such as hepatitis, cancer, and influenza. Since the market is lucrative, vendors are investing heavily in R&D activities to develop innovative vaccines. This has resulted in the introduction of new technologies such as dendritic cell vaccine preparation, DNA vaccine preparation, T-cell receptor peptide vaccine preparation, and recombinant vector vaccine preparation.'
According to the report, the growing need to prevent viral infections has increased the use of vaccines across the globe. This is one of the major factors driving the growth of the market.
Further, the report also discusses that the shortage of vaccines to meet the market demand in the developing countries is adversely affecting the growth of the Global Human Vaccines market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
Key Topics Covered:
1. Executive Summary
2. Introduction
3. Market Coverage
Market Overview
Key Products
4. Market Landscape
5. Geographical Segmentation
6. Key Leading Countries
7. Rate of Incidence and Prevalence
8. Vendor Landscape
9. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 GlaxoSmithKline plc
15.2 Sanofi S.A.
15.3 Pfizer Inc.
15.4 Merck and Co. Inc.
16. Other Reports in this Series